Cargando…

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer

Prostate cancer (PCa) is the most common male malignancy and the fifth leading cause of cancer death in men worldwide. Prostate cancer cells are characterized by a hybrid glycolytic/oxidative phosphorylation phenotype determined by androgen receptor signaling. An increased lipogenesis and cholestero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasorsa, Francesco, di Meo, Nicola Antonio, Rutigliano, Monica, Ferro, Matteo, Terracciano, Daniela, Tataru, Octavian Sabin, Battaglia, Michele, Ditonno, Pasquale, Lucarelli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863674/ https://www.ncbi.nlm.nih.gov/pubmed/36674430 http://dx.doi.org/10.3390/ijms24020910

Ejemplares similares

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)

Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
por: Lasorsa, Francesco, et al.
Publicado: (2023)

MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome
por: Lucarelli, Giuseppe, et al.
Publicado: (2022)

Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)

Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review
por: Loizzo, Davide, et al.
Publicado: (2022)

Emerging Urinary Markers of Renal Injury in Obstructive Nephropathy
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2020)

Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
por: Ferro, Matteo, et al.
Publicado: (2023)

MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation
por: Lucarelli, Giuseppe, et al.
Publicado: (2023)

Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
por: Ferro, Matteo, et al.
Publicado: (2021)

Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics
por: Ragone, Rosa, et al.
Publicado: (2016)

Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies
por: Ferro, Matteo, et al.
Publicado: (2020)

Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement
por: Ferro, Matteo, et al.
Publicado: (2023)

Narrative review of Mediterranean diet in Cilento: longevity and potential prevention for prostate cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma
por: De Palma, Giuseppe, et al.
Publicado: (2016)

Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
por: Vavallo, Antonio, et al.
Publicado: (2014)

The Efficacy of Flogofilm(®) in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
por: Barone, Biagio, et al.
Publicado: (2023)

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
por: Gigante, Margherita, et al.
Publicado: (2015)

Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
por: Ferro, Matteo, et al.
Publicado: (2017)

Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report
por: Bettocchi, Carlo, et al.
Publicado: (2019)

Radiomics in prostate cancer: an up-to-date review
por: Ferro, Matteo, et al.
Publicado: (2022)

Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2015)

Multi-omics approach reveals the secrets of metabolism of clear cell—renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2016)

Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2018)

Immunometabolic reprogramming, another cancer hallmark
por: Kumar, Vijay, et al.
Publicado: (2023)

Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2015)

Beyond PSA: The Role of Prostate Health Index (phi)
por: Ferro, Matteo, et al.
Publicado: (2020)

Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis
por: Allen, Charles N. S., et al.
Publicado: (2022)

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)

Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Management of severe complications following penile surgery for erectile dysfunction and Peyronie disease: Three case reports
por: Bettocchi, Carlo, et al.
Publicado: (2020)

Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
por: Ferro, Matteo, et al.
Publicado: (2016)

Intermediate-term oncological and functional outcomes in prostate cancer patients treated with perineal robot-assisted radical prostatectomy: A single center analysis
por: Carbonara, Umberto, et al.
Publicado: (2023)

Molecular Imaging Diagnosis of Renal Cancer Using (99m)Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
por: Tataru, Octavian Sabin, et al.
Publicado: (2023)

Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor
por: La Civita, Evelina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4l7vkiqhr9qhgjctv44rboptrk